| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/27/2004 | WO2004044164A2 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044163A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044144A2 Methods for inducing regeneration, remyelination, and hypermyelination of nervous tissue |
| 05/27/2004 | WO2004044137A2 Modified oligomeric compounds and compositions for use in gene modulation |
| 05/27/2004 | WO2004044068A1 Disinfecting dip compositions and related methods |
| 05/27/2004 | WO2004044046A2 Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 05/27/2004 | WO2004044009A1 Isolating chondroitin sulfate |
| 05/27/2004 | WO2004043993A2 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 05/27/2004 | WO2004043992A2 Imaging protein-protein interactions in living subjects |
| 05/27/2004 | WO2004043985A1 Substituted 9a-n-{n'-[4-(sulfonyl)phenyl]carbamoyl} derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithromycin a and 5-0-desosaminyl-9-deoxo-9-di-hydro-9a-aza-9a-homoerithronolide a |
| 05/27/2004 | WO2004043983A1 4-methyl-2-oxo-2h-1-benzopyran-7yl 5-thio-beta-d-xylopyranoside derivative, method for preparing same and pharmaceutical composition containing same |
| 05/27/2004 | WO2004043963A1 Pyrrolobenzodiazepines |
| 05/27/2004 | WO2004043960A1 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof |
| 05/27/2004 | WO2004043959A1 Novel parp inhibitors |
| 05/27/2004 | WO2004043958A1 Fused heterocyclic compounds |
| 05/27/2004 | WO2004043955A1 Rhodanine derivatives and pharmaceutical compositions containing them |
| 05/27/2004 | WO2004043953A1 Pyrimidine compounds |
| 05/27/2004 | WO2004043951A1 Pyrazole derivatives as modulators of peroxisome proliferator activated receptors |
| 05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | WO2004043940A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/27/2004 | WO2004043933A1 Ophthalmic compositions for treating ocular hypertension |
| 05/27/2004 | WO2004043932A1 Ophthalmic compositions for treating ocular hypertension |
| 05/27/2004 | WO2004043924A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/27/2004 | WO2004043920A1 Polymorphs of bicifadine hydrochloride |
| 05/27/2004 | WO2004043913A2 Hetero-substituted benzimidazole compounds and antiviral uses thereof |
| 05/27/2004 | WO2004043491A1 Remedies for vertebral canal stenosis |
| 05/27/2004 | WO2004043485A1 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
| 05/27/2004 | WO2004043479A1 Irrigation solution and method for inhibition of tumor cell adhesion, pain and inflammation |
| 05/27/2004 | WO2004043478A1 Cyclooxygenase-2 inhibitory withanolide compositions and method |
| 05/27/2004 | WO2004043477A1 Dietary supplement comprising parthenolide |
| 05/27/2004 | WO2004043476A1 Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
| 05/27/2004 | WO2004043473A1 Composition for restoring damaged skin |
| 05/27/2004 | WO2004043472A1 Combination product of inhibitor of the src family of non-receptor tyrosine kinases and gemcitabine |
| 05/27/2004 | WO2004043471A1 Antipruritic drug |
| 05/27/2004 | WO2004043470A1 The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| 05/27/2004 | WO2004043469A1 Anti-aging skin care composition and uses thereof |
| 05/27/2004 | WO2004043467A1 Anti-viral compounds |
| 05/27/2004 | WO2004043466A1 Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia |
| 05/27/2004 | WO2004043465A1 Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions |
| 05/27/2004 | WO2004043464A1 Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases |
| 05/27/2004 | WO2004043461A1 Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome |
| 05/27/2004 | WO2004043459A1 Treatment of mesothelioma |
| 05/27/2004 | WO2004043457A1 Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
| 05/27/2004 | WO2004043456A1 Cholesterol absorption inhibitors for the treatment of demyelination |
| 05/27/2004 | WO2004043455A1 Use of the distrontium salt of the acid 2-[n,n-di(carboxymethyl)amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain |
| 05/27/2004 | WO2004043454A1 Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by anticancer agents |
| 05/27/2004 | WO2004043453A1 Lysine mixture and apparatus and method for administering lysine |
| 05/27/2004 | WO2004043452A1 3,5,3’-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof |
| 05/27/2004 | WO2004043451A1 Composition for the treatment of gastrointestinal disorders |
| 05/27/2004 | WO2004043450A1 Sorbic acid as an anti-infective agent against coccidia |
| 05/27/2004 | WO2004043449A1 Pharmaceutical pellets comprising tamsulosin and a process for making the same |
| 05/27/2004 | WO2004043448A1 Pharmaceutical pellets comprising tamsulosin |
| 05/27/2004 | WO2004043447A2 Compositions and methods for treating or preventing hearing impairment |
| 05/27/2004 | WO2004043446A2 Combination product for controlling insect pests |
| 05/27/2004 | WO2004043445A1 Topical parasiticide formulations and methods of treatment |
| 05/27/2004 | WO2004043444A1 Treatment of amyotrophic lateral sclerosis with nimesulide |
| 05/27/2004 | WO2004043443A2 Drugs for sexual dysfunctions |
| 05/27/2004 | WO2004043440A1 Fast-disintegrating solid dosage forms being not friable and comprising pullulan |
| 05/27/2004 | WO2004043439A1 Improved formulations containing substituted imidazole derivatives |
| 05/27/2004 | WO2004043437A1 Method for the preparation of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby |
| 05/27/2004 | WO2004043434A1 Oral testosterone delivery system with improved sustained release |
| 05/27/2004 | WO2004043433A2 Pharmaceutical antiviral compositions |
| 05/27/2004 | WO2004043431A1 Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally |
| 05/27/2004 | WO2004043429A1 Combination therapy for postmenopausal female sexual dysfunction comprising an androgen, and at least one agent selected from an estrogen and an anti-muscarinic |
| 05/27/2004 | WO2004043428A2 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/27/2004 | WO2004043424A1 Method of stimulating hair growth using benzopyrans |
| 05/27/2004 | WO2004043412A1 Water soluble monomers and polymers for protecting subtrates from ultraviolet light |
| 05/27/2004 | WO2004043408A2 Gpc15: methods and compositions for treating cancer |
| 05/27/2004 | WO2004043406A2 ENGINEERED RNAi ADENOVIRUS SILENCING EXPRESSION (ERASE) OF DNA REPAIR PROTEINS |
| 05/27/2004 | WO2004043405A2 Polysaccharide vaccine for staphylococcal infections |
| 05/27/2004 | WO2004043396A2 Modified carbamate-containing prodrugs and methods of synthesizing same |
| 05/27/2004 | WO2004043393A2 Compositions for diabetes treatment and prophylaxis |
| 05/27/2004 | WO2004043392A2 Mucin synthesis inhibitors |
| 05/27/2004 | WO2004043390A2 Pharmaceutical compositions and methods of using taxane derivatives |
| 05/27/2004 | WO2004043389A2 Methods of treating cancer and related methods |
| 05/27/2004 | WO2004043387A2 Compositions and methods for cancer diagnosis and therapy |
| 05/27/2004 | WO2004043384A2 Novel pharmacophore for the discovery and testing of na, k-atpase inhibitor compositions and methods for their use in treating cardiovascular diseases and conditions |
| 05/27/2004 | WO2004043381A2 Compositions and methods for prolonging survival of platelets |
| 05/27/2004 | WO2004043378A2 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 05/27/2004 | WO2004043377A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 05/27/2004 | WO2004043375A2 Pharmaceutical compositions and methods of using taxane derivatives |
| 05/27/2004 | WO2004043374A2 Methods and compositions for treating cancer using proteasome inhibitors |
| 05/27/2004 | WO2004043369A2 Sulfonamides |
| 05/27/2004 | WO2004043367A2 Fused heterocyclic compounds and use thereof |
| 05/27/2004 | WO2004043365A2 Method for treatment of premature ejaculation in humans |
| 05/27/2004 | WO2004043362A2 Acyl guanidine compounds and use thereof |
| 05/27/2004 | WO2004043360A2 Methods of using vitamin d compounds in the treatment of myelodysplastic syndromes |
| 05/27/2004 | WO2004043359A2 N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor |
| 05/27/2004 | WO2004043358A2 Formulations of low solubility bioactive agents and processes for making the same |
| 05/27/2004 | WO2004043357A2 Method of making, and the use of cytotoxic agents containing elemental selenium |
| 05/27/2004 | WO2004043355A2 Alpha, alpha-disubstituted benzylglycine derivatives as hiv protease inhibitors |
| 05/27/2004 | WO2004043352A2 Histone deacetylase inhibitors for the treatment of ocular neovascular or edematous disorders and diseases |
| 05/27/2004 | WO2004043350A2 PURIFIED COMPOUNDS THAT INHIBIT INTRACELLULAR α4/PAXILLIN BINDING |
| 05/27/2004 | WO2004043349A2 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 05/27/2004 | WO2004043348A2 Histone deacetylase inhibitors for treating degenerative diseases of the eye |
| 05/27/2004 | WO2004043342A2 Methods of treating injuries of the nervous system associated with hemorrhage |
| 05/27/2004 | WO2004043340A2 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 05/27/2004 | WO2004043339A2 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 05/27/2004 | WO2004043338A2 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 05/27/2004 | WO2004043337A2 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |